1 Introduction
1.1 What Is This Report About?
1.2 Hormonal Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Hormonal Disorders Market, Canada
2.1 Hormonal Disorders Market, Canada, Revenue ($m), 2024-2036
2.1.1 Thyroid Function Tests Market, Canada, Revenue ($m), by Segment, 2024-2036
2.2 Hormonal Disorders Market, Canada, Volume (Units), 2024-2036
2.2.1 Thyroid Function Tests Market, Canada, Volume (Units), by Segment, 2024-2036
2.3 Hormonal Disorders Market, Canada, Average Price ($), 2024-2036
2.4 Hormonal Disorders Market, Canada, Company Share by Revenue ($m), 2025
3 Hormonal Disorders Market Pipeline Products
3.1 Hormonal Disorders Market Pipeline Products
3.2 Hormonal Disorders - Pipeline Products by Stage of Development
3.3 Hormonal Disorders - Pipeline Products by Segment
3.4 Hormonal Disorders - Pipeline Products by Territory
3.5 Hormonal Disorders - Pipeline Products by Regulatory Path
3.6 Hormonal Disorders - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in Canada, Hormonal Disorders Market
4.1 Siemens Healthineers AG
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Roche Diagnostics International Ltd
4.3.1 Company Overview
4.4 Beckman Coulter Inc
4.4.1 Company Overview
4.5 Ortho Clinical Diagnostics Holdings Ltd (Inactive)
4.5.1 Company Overview
5 Recent Developments
5.1 Corporate Communications
5.1.1 Nov 14, 2025: COSCIENS Biopharma Announces Leadership Change
5.1.2 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.2 Financial Announcements
5.2.1 Mar 25, 2026: COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
5.2.2 Nov 11, 2025: COSCIENS Biopharma Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update
5.3 Other Significant Developments
5.3.1 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.4 Strategy And Business Planning
5.4.1 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the Analyst Consulting
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Hormonal Disorders Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 2: Thyroid Function Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 3: Hormonal Disorders Market, Canada, Volume (Units), 2024-2036
Table 4: Thyroid Function Tests Market, Canada, Volume (Units), 2024-2036
Table 5: Hormonal Disorders Market, Canada, Average Price ($), 2024-2036
Table 6: Hormonal Disorders Market, Canada, Company Share by Revenue ($m), USD Constant, 2025
Table 7: Hormonal Disorders Market Pipeline Products
Table 8: Hormonal Disorders - Pipeline Products by Stage of Development
Table 9: Hormonal Disorders Companies - Pipeline Products by Stage of Development
Table 10: Hormonal Disorders - Pipeline Products by Segment
Table 11: Hormonal Disorders - Pipeline Products by Territory
Table 12: Hormonal Disorders - Pipeline Products by Regulatory Path
Table 13: Hormonal Disorders - Pipeline Products by Estimated Approval Date
Table 14: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Hormonal Disorders Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 2: Thyroid Function Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 3: Hormonal Disorders Market, Canada, Volume (Units), 2024-2036
Figure 4: Thyroid Function Tests Market, Canada, Volume (Units), 2024-2036
Figure 5: Hormonal Disorders Market, Canada, Company Share (%), 2025
Figure 6: Hormonal Disorders - Pipeline Products by Stage of Development
Figure 7: Hormonal Disorders - Pipeline Products by Segment
Figure 8: Hormonal Disorders - Pipeline Products by Territory
Figure 9: Hormonal Disorders - Pipeline Products by Regulatory Path
Figure 10: Hormonal Disorders - Pipeline Products by Estimated Approval Date
